ImmunityBio (IBRX) Cash from Operations (2014 - 2026)
ImmunityBio (IBRX) reported Cash from Operations of 75400000.0 for Q1 2026, up 12.23% year-over-year from 67184285.86 in Q1 2025, and down 7.14% quarter-over-quarter from 70378000.0 in Q4 2025.
ImmunityBio (IBRX) Cash from Operations (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of Cash from Operations data on file, last reported at 75400000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 75400000.0, up 12.23% year-over-year; the trailing twelve-month figure through Mar 2026 was 294431000.0 (up 20.46% YoY), and the FY2025 annual result was 304936000.0, up 22.06% from the prior year.
- Cash from Operations retreated to 75400000.0 in Q1 2026 per IBRX's latest filing, from 70378000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 68858000.0 in Q3 2025 and troughed at 115271000.0 in Q4 2023.
- A 5-year average of 86814000.0 and a median of 85144000.0 in 2024 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations tumbled 31.12% in 2022, then jumped 30.28% in 2025.
- A 5-year view of Cash from Operations shows it stood at 90727000.0 in 2022, then declined by 27.05% to 115271000.0 in 2023, then gained by 26.14% to 85144000.0 in 2024, then rose by 17.34% to 70378000.0 in 2025, then declined by 7.14% to 75400000.0 in 2026.
- Business Quant data shows IBRX's Cash from Operations at 75400000.0 in Q1 2026, 70378000.0 in Q4 2025, and 68858000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | -75.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.40 Mn |
| Mar 31, 2026 | -75.40 Mn |
| Dec 31, 2025 | -70.38 Mn |
| Dec 31, 2025 | -70.38 Mn |
| Sep 30, 2025 | -68.86 Mn |
| Sep 30, 2025 | -68.86 Mn |
| Jun 30, 2025 | -79.80 Mn |
| Jun 30, 2025 | -79.80 Mn |
| Mar 31, 2025 | -85.91 Mn |
| Mar 31, 2025 | -85.91 Mn |
| Dec 31, 2024 | -85.14 Mn |
| Dec 31, 2024 | -85.14 Mn |
| Sep 30, 2024 | -98.76 Mn |
| Sep 30, 2024 | -98.76 Mn |
| Jun 30, 2024 | -100.35 Mn |
| Jun 30, 2024 | -100.35 Mn |
| Mar 31, 2024 | -106.98 Mn |
| Mar 31, 2024 | -106.98 Mn |
| Dec 31, 2023 | -115.27 Mn |
| Dec 31, 2023 | -115.27 Mn |